[15] Chockalingam, A.  2008; “World Hypertension Day and Global awareness.”   An umbrella organization of 85 national hypertension societies and leagues.  Can J Cardio 24(6):  4441-444.  Also, cited in 2010; U.S. Department of Health & Human Services @ http://www.hhs.gov Also  indorsed by the Amer H Assoc on Feb. 22, 2010 via teleconference with Fleming, D., MD dir. Public health, Seattle/King County, WA. Also, U.S Food and Drug Admin. Willett, W., MD, DPH, Stare, J., Prof. of Epidemiology and Nutrition at Harvard School of Public Health, Boston; “A Population-Based Policy and System Change Approach to Prevent and Control Hypertension.”  © 2010; Scout News, LLC.  High Blood Pressure a ‘Neglected Disease’.  

[16] Manson, J.E., Bassuk, S.S., Obesity in the United States.  A fresh look at its high toll.  JAMA 2004; 289:229.

[17] Peeters, A., Barendregt, J., Willekens, F., et al.  Obesity in adulthood and its consequences for life expectancy:  a life-table analysis.  Ann Intern Med 2004; 138: 24. Also, cited in 2009; World Health Org (WHO) @ http://www.who.int./dietphysicalactivity/public/obesity/en/  Obesity and overweight Facts.

[18] Nielsen, S. J., Popkin, B.M:  Patterns and trends in food portion sizes.  2003; JAMA 289:450. 

[19] Erlinge, D., Ekman, R., Thulin, T., et al.  Neuropeptide Y-like immunoreactivity and hypertension.  J Hypertens 1992; 10:1221-1225.

[20] Widgren, B.R., Wikstrand, J. Berglund, G. et al.  Increased response to physical and mental stress in men with hypertensive parents.  Hypertension 1992; 20: 606-611.  Cited again in:  Hypertens 2002; 18: 520-524.

[21] Pickering, T.G. Does psychological stress contribute to the development of hypertension and coronary heart disease?  Eur J Clin Pharmacol 2004; 49:S1-S6.

[22] Haffner, S.M., Ferrannini, E., Mazda, H.P., Clustering of cardiovascular risk factors in confirmed prehypertensive individuals, ACP Medicine, Textbook of Cardiovascular Medicine:  ©2006 by Lippincott Williams & Wilkins.

[23] Bonora, E., Bonadonna, R.C.  In vivo glucose metabolism in obsess and type ll and diabetic subjects with or without hypertension.  Diabetes 1999; 43:764-772.  Revised in the ACP Medicine, Textbook of Cardiovascular Medicine:  ©2006 edition by Lippincott…

[24] ACP Medicine, Textbook of Cardiovascular Medicine: Pathophysiology Studies. ©2006 by Lippincott…

[25] Coroni-Huntly, J., LaCroix, A., Havlik, R. Impact of hypertension in the United States: the National Health and Nutrition Examination Survey; Epidemiologic report in:  Arch Intern Med 2007; 149:780-788   http://archinte.ama.assn.org/.  

[26] Kannel, W.B. Framingham study insights into hypertensive risk of cardiovascular disease. Dept. of Med. Evans Memorial Research Found. Boston Univ. School of Medicine. MA.   Hypertens Res1995; 18:181-196. Cited again in: JAMA 2008; 300(21): 2545-2547. http://jama.ama.assn.org/

[27] Sprecher, D. How deadly is the “deadly quartet” A post-CABG evaluation?  J Amer Coll Card. 2009: Vol 36, Issue 4, Pg. 1159-1165. Science Direct, Elsevier, B.V.  

[28] National High Blood Pressure Education Program Working Group.  Working Group reports on hypertension in diabetes.  Bethesda, MD:  National Heart, Lung, and Blood Institute, and the National Institutes of Health, 1995, 2000, 2004. Web site: http:// www.guideline.gov// 

[29] National High Blood Pressure Education Program Working Group…2004; http:// www.guideline.gov//

[30] Setaro JF, Black HR. Refractory hypertension. N Engl J Med 1992; 327:543–547. http://content.nejm.org// Revised in 2006; by permission from N Engl J Med © approved. Marvin, M., Setaro, J.F. July 27, 2006. Vol. 355(4)385-392. 

[31] Rudd, P., Marshall, G.  Anti-hypertensive medication-taking behavior:  out/patient patterns and implications.  In:  Rosenfeld, J. Ed.  (Med. Textbook):  Hypertension control in the community.  London:  John Libby & Co. 1995; 232-236.

[32] Tifft, Charles MD. Joint National Committee Vl: Individualized Versus Indiscriminate Therapy for Hypertension.  ©2000; 2:243-246. By Current Science Inc. Boston, MA  http://springerlink.com//

Short Bio of Dr. Gary D. Goldberg, PhD 

Over 30 years experience in the Medical field, At UCLA and Pacific Hospital of the Valley, as a Chief Technologist and Analyst, Visiting Professor and Instructor for continuing education at UCLA School of Nursing and Writer/Speaker at the School of Medicine from 1995-2008.

From 2003-2008 Dr. Goldberg has collaborated and published through Blackwell Publishing Co. (Medical Division), and Journal of American College of Cardiology plus 15, published abstracts through UCLA Dept. of Internal Medicine and the Dept. of Cardiology.

Current title: Clinical Professor of Medical Education with Angeles College of Nursing, in Los Angeles, Ca.  

Dr. Goldberg has written two major academic course textbooks for Angele College of Nursing and has represented advanced nursing education course curriculum through the State Dept. of California and approved by the ANA for CEU(s) and the AMA CMU Level 1 Credit for physicians.

His wife, Cindy L. Capute-Goldberg, has been a registered nurse for over 17 years and has managed a 200-bed acute care facility with over 100, professional nurses from RN’s through CNA in the Los Angeles area.  She has co-authored with Dr. Goldberg in 2005, a manuscript presented to the Cardiology-Electrophysiology Research Group (i.e., DMPG), that has changed the dynamics of electro-static reading with regards to acute atrial anomalies. 

This finding allowed the author to publish the ‘Goldberg Protocol’  for Cardiac placements in the field and under the Dept. of Medicine Chair, in using a tilt-table with the 12 +3 Leads or the vector positioning for additional cardiac patient information.

To reach Dr. Gary D. Goldberg, for comments and/or consultation, please use e-mail address:  or cell phone contact:  818-610-9017. 

Back to Top

Bookmark this page

Digg Facebook Google Bookmarks Stumbleupon Livejournal Twitter